Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... by Jiří Plášek (21805048)

“…</p>Conclusion<p>Plasma secretoneurin levels are decreased after catheter ablation for atrial fibrillation; patients with AF produce lower SN levels than healthy individuals. …”

<i>jun-1</i> mutants are highly susceptible to both Bt strains, while <i>elt-2</i> silencing decreased survival on Bt679 but increased survival on Bt247. by Alejandra Zárate-Potes (9415842)

DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

“…WT later in life [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref091" target="_blank">91</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref092" target="_blank">92</a>]; we note that, although comparison of scores across experiments is not possible due to variation in baseline values, the swimming rate of <i>daf-16(mgDf50)</i> control animals was slightly lower than WT controls on the same day of life (in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1C</a>; mean of 46.17 head thrashes/30 sec. for <i>daf-16</i> vs. 52.17 head thrashes/30 sec. for WT on day 10). …”

Video5_Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex.MOV by Wesam S. Ahmed (10170053)

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

Demographic data of the ED visits due hand injuries and subsequent hand operations, 2020 compared with mean of reference years 2017–2019. by Ilari Kuitunen (11084096)

Effect of dexmedetomidine (5 μg∙kg⁻¹ or 50 μg∙kg⁻¹) at experimental recording (Protocol 1). by Yoichiro Kitajima (4319455)

Subjects:

Sample means, SDs, and selected correlations. by Erik Lykke Mortensen (7239170)

S5 Fig - by Meihui Chen (1670020)

Results of two-way repeated measure ANOVAs for various HRV indicators. by Duyan Geng (12072181)

Subjects:

Tension ratings at different period under taVNS or staVNS. by Duyan Geng (12072181)

Subjects:

Descriptive statistics of HRV indicators among the three recordings (baseline, stimulation, recovery) under taVNS or staVNS conditions. by Duyan Geng (12072181)

Subjects:

Ear stimulation targets used of taVNS or staVNS. by Duyan Geng (12072181)

Subjects:

Descriptive statistics of Stimulation intensity, pain ratings and tension ratings under different stimulation conditions. by Duyan Geng (12072181)

Subjects:

Differences in stimulation intensity between various parameters. by Duyan Geng (12072181)

Subjects:

Procedure for study 1. by Duyan Geng (12072181)

Subjects:

Stimulation response by parameter over time. by Duyan Geng (12072181)

Subjects:

Procedure for study 2. by Duyan Geng (12072181)

Subjects:

Fig 4 - by Duyan Geng (12072181)

Subjects:

Fig 6 - by Duyan Geng (12072181)

Subjects: